{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:51:24Z","timestamp":1772164284638,"version":"3.50.1"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"3","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Myc proteins regulate cell growth and are oncogenic in many cancers. Although these proteins are validated molecular anticancer targets, new therapies aimed at modulating myc have yet to emerge. A benzodiazepine (Bz-423) that was discovered in efforts to find new drugs for lupus was found recently to have antiproliferative effects on Burkitt's lymphoma cells. We now show that the basis for the antiproliferative effects of Bz-423 is the rapid and specific depletion of c-myc protein, which is coupled to growth-suppressing effects on key regulators of proliferation and cell cycle progression. c-Myc is depleted as a result of signals coupled to Bz-423 binding its molecular target, the oligomycin sensitivity-conferring protein subunit of the mitochondrial F1Fo-ATPase. Bz-423 inhibits F1Fo-ATPase activity, blocking respiratory chain function and generating superoxide, which at growth-inhibiting concentrations triggers proteasomal degradation of c-myc. Bz-423-induced c-myc degradation is independent of glycogen synthase kinase but is substantially blocked by mutation of the phosphosensitive residue threonine 58, which when phosphorylated targets c-myc for ubiquitination and subsequent proteasomal degradation. Collectively, this work describes a new lead compound, with drug-like properties, which regulates c-myc by a novel molecular mechanism that may be therapeutically useful. (Cancer Res 2006; 66(3): 1775-82)<\/jats:p>","DOI":"10.1158\/0008-5472.can-05-3476","type":"journal-article","created":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T11:48:20Z","timestamp":1138794500000},"page":"1775-1782","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The Immunomodulatory Benzodiazepine Bz-423 Inhibits B-Cell Proliferation by Targeting c-Myc Protein for Rapid and Specific Degradation"],"prefix":"10.1158","volume":"66","author":[{"given":"Thomas B.","family":"Sundberg","sequence":"first","affiliation":[{"name":"1Chemistry, Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina M.","family":"Ney","sequence":"additional","affiliation":[{"name":"1Chemistry, Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chitra","family":"Subramanian","sequence":"additional","affiliation":[{"name":"2Pediatrics, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Anthony W.","family":"Opipari","sequence":"additional","affiliation":[{"name":"3Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary D.","family":"Glick","sequence":"additional","affiliation":[{"name":"1Chemistry, Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2006,2,1]]},"reference":[{"key":"2022061622284394500_B1","doi-asserted-by":"crossref","unstructured":"Pelengaris S, Khan M, Evan G. c-MYC: more than just a matter of life and death. Nat Rev Cancer\u20082002;2:764\u20136.","DOI":"10.1038\/nrc904"},{"key":"2022061622284394500_B2","doi-asserted-by":"crossref","unstructured":"Atchley WR, Fitch WM. Myc and Max: molecular evolution of a family of proto-oncogene products and their dimerization partner. Proc Natl Acad Sci U S A\u20081995;92:10217\u201321.","DOI":"10.1073\/pnas.92.22.10217"},{"key":"2022061622284394500_B3","doi-asserted-by":"crossref","unstructured":"Coller HA, Grandori C, Tamayo P, et al. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc Natl Acad Sci U S A\u20082000;97:3260\u20135.","DOI":"10.1073\/pnas.97.7.3260"},{"key":"2022061622284394500_B4","doi-asserted-by":"crossref","unstructured":"Gartel AL, Ye X, Goufman E, et al. Myc represses the p21(WAF1\/CIP1) promoter and interacts with Sp1\/Sp3. Proc Natl Acad Sci U S A\u20082001;98:45105.","DOI":"10.1073\/pnas.081074898"},{"key":"2022061622284394500_B5","doi-asserted-by":"crossref","unstructured":"Nesbit CE, Tersak JM, Prochownik EV. MYC oncogenes and human neoplastic disease. Oncogene\u20081999;18:3004\u201316.","DOI":"10.1038\/sj.onc.1202746"},{"key":"2022061622284394500_B6","doi-asserted-by":"crossref","unstructured":"Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol\u20081999;19:1\u201311.","DOI":"10.1128\/MCB.19.1.1"},{"key":"2022061622284394500_B7","doi-asserted-by":"crossref","unstructured":"Battey J, Moulding C, Taub R, et al. The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma. Cell\u20081983;34:779\u201387.","DOI":"10.1016\/0092-8674(83)90534-2"},{"key":"2022061622284394500_B8","doi-asserted-by":"crossref","unstructured":"Smith JB, Wickstrom E. Inhibition of tumorigenesis in a murine B-cell lymphoma transplant model by c-Myc complementary oligonucleotides. Adv Exp Med Biol\u20081998;451:17\u201322.","DOI":"10.1007\/978-1-4615-5357-1_3"},{"key":"2022061622284394500_B9","doi-asserted-by":"crossref","unstructured":"Huang Y, Snyder R, Kligshteyn M, Wickstrom E. Prevention of tumor formation in a mouse model of Burkitt's lymphoma by 6 weeks of treatment with anti-c-myc DNA phosphorothioate. Mol Med\u20081995;1:647\u201358.","DOI":"10.1007\/BF03401605"},{"key":"2022061622284394500_B10","doi-asserted-by":"crossref","unstructured":"Blatt NB, Bednarski JJ, Warner RE, et al. Benzodiazepine-induced superoxide signals B cell apoptosis: mechanistic insight and potential therapeutic utility. J Clin Invest\u20082002;110:1123\u201332.","DOI":"10.1172\/JCI0216029"},{"key":"2022061622284394500_B11","unstructured":"Boitano A, Ellman JA, Glick GD, Opipari AW, Jr. The proapoptotic benzodiazepine Bz-423 affects the growth and survival of malignant B cells. Cancer Res\u20082003;63:6870\u20136."},{"key":"2022061622284394500_B12","doi-asserted-by":"crossref","unstructured":"Bednarski JJ, Warner RE, Rao T, et al. Attenuation of autoimmune disease in Fas-deficient mice by treatment with a cytotoxic benzodiazepine. Arthritis Rheum\u20082003;48:757\u201366.","DOI":"10.1002\/art.10968"},{"key":"2022061622284394500_B13","doi-asserted-by":"crossref","unstructured":"Johnson KM, Chen X, Boitano A, Swenson L, Opipari AW, Jr., Glick GD. Identification and validation of the mitochondrial F(1)F(0)-ATPase as the molecular target of the immunomodulatory benzodiazepine bz-423. Chem Biol\u20082005;12:485\u201396.","DOI":"10.1016\/j.chembiol.2005.02.012"},{"key":"2022061622284394500_B14","doi-asserted-by":"crossref","unstructured":"Bunin BA, Plunkett MJ, Ellman JA. The combinatorial synthesis and chemical and biological evaluation of a 1,4-benzodiazepine library. Proc Natl Acad Sci U S A\u20081994;91:4708\u201312.","DOI":"10.1073\/pnas.91.11.4708"},{"key":"2022061622284394500_B15","doi-asserted-by":"crossref","unstructured":"Djurhuus R. Ornithine decarboxylase (EC 4.1.1.17) assay based upon the retention of putrescine by a strong cation-exchange paper. Anal Biochem\u20081981;113:352\u20135.","DOI":"10.1016\/0003-2697(81)90088-9"},{"key":"2022061622284394500_B16","doi-asserted-by":"crossref","unstructured":"Nitta T, Igarashi K, Yamamoto N. Polyamine depletion induces apoptosis through mitochondria-mediated pathway. Exp Cell Res\u20082002;276:120\u20138.","DOI":"10.1006\/excr.2002.5517"},{"key":"2022061622284394500_B17","doi-asserted-by":"crossref","unstructured":"Chang BD, Watanabe K, Broude EV, et al. Effects of p21Waf1\/Cip1\/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci U S A\u20082000;97:4291\u20136.","DOI":"10.1073\/pnas.97.8.4291"},{"key":"2022061622284394500_B18","unstructured":"Voigt W. Sulforhodamine B assay and chemosensitivity. Methods Mol Med\u20082005;110:39\u20138."},{"key":"2022061622284394500_B19","doi-asserted-by":"crossref","unstructured":"An S, Park MJ, Park IC, Hong SI, Knox K. Procaspase-3 and its active large subunit localized in both cytoplasm and nucleus are activated following application of apoptotic stimulus in Ramos-Burkitt lymphoma B cells. Int J Mol Med\u20082003;12:311\u20137.","DOI":"10.3892\/ijmm.12.3.311"},{"key":"2022061622284394500_B20","doi-asserted-by":"crossref","unstructured":"Coffino P. Regulation of cellular polyamines by antizyme. Nat Rev Mol Cell Biol\u20082001;2:188\u201394.","DOI":"10.1038\/35056508"},{"key":"2022061622284394500_B21","doi-asserted-by":"crossref","unstructured":"Thomas T, Thomas TJ. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci\u20082001;58:244\u201358.","DOI":"10.1007\/PL00000852"},{"key":"2022061622284394500_B22","doi-asserted-by":"crossref","unstructured":"Bello-Fernandez C, Packham G, Cleveland JL. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc Natl Acad Sci U S A\u20081993;90:7804\u20138.","DOI":"10.1073\/pnas.90.16.7804"},{"key":"2022061622284394500_B23","doi-asserted-by":"crossref","unstructured":"Murray AW. Recycling the cell cycle: cyclins revisited. Cell\u20082004;116:221\u20134.","DOI":"10.1016\/S0092-8674(03)01080-8"},{"key":"2022061622284394500_B24","doi-asserted-by":"crossref","unstructured":"Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev\u20081999;13:1501\u201312.","DOI":"10.1101\/gad.13.12.1501"},{"key":"2022061622284394500_B25","doi-asserted-by":"crossref","unstructured":"Fernandez PC, Frank SR, Wang L, et al. Genomic targets of the human c-Myc protein. Genes Dev\u20082003;17:1115\u201329.","DOI":"10.1101\/gad.1067003"},{"key":"2022061622284394500_B26","doi-asserted-by":"crossref","unstructured":"Cobrinik D. Pocket proteins and cell cycle control. Oncogene\u20082005;24:2796\u2013809.","DOI":"10.1038\/sj.onc.1208619"},{"key":"2022061622284394500_B27","doi-asserted-by":"crossref","unstructured":"Zarkowska T, Mittnacht S. Differential phosphorylation of the retinoblastoma protein by G1-S cyclin-dependent kinases. J Biol Chem\u20081997;272:12738\u201346.","DOI":"10.1074\/jbc.272.19.12738"},{"key":"2022061622284394500_B28","doi-asserted-by":"crossref","unstructured":"Banerji L, Glassford J, Lea NC, Thomas NS, Klaus GG, Lam EW. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells. Oncogene\u20082001;20:7352\u201367.","DOI":"10.1038\/sj.onc.1204951"},{"key":"2022061622284394500_B29","doi-asserted-by":"crossref","unstructured":"Alessi F, Quarta S, Savio M, et al. The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity. Exp Cell Res\u20081998;245:8\u201318.","DOI":"10.1006\/excr.1998.4216"},{"key":"2022061622284394500_B30","doi-asserted-by":"crossref","unstructured":"Zheng Y, Shi Y, Tian C, et al. Essential role of the voltage-dependent anion channel (VDAC) in mitochondrial permeability transition pore opening and cytochrome c release induced by arsenic trioxide. Oncogene\u20082004;23:1239\u201347.","DOI":"10.1038\/sj.onc.1207205"},{"key":"2022061622284394500_B31","doi-asserted-by":"crossref","unstructured":"Luscher B. Function and regulation of the transcription factors of the Myc\/Max\/Mad network. Gene\u20082001;277:1\u201314.","DOI":"10.1016\/S0378-1119(01)00697-7"},{"key":"2022061622284394500_B32","doi-asserted-by":"crossref","unstructured":"Hu X, Bies J, Wolff L. Interferon \u03b2 increases c-Myc proteolysis in mouse monocyte\/macrophage leukemia cells. Leuk Res\u20082005;29:1307\u201314.","DOI":"10.1016\/j.leukres.2005.04.002"},{"key":"2022061622284394500_B33","doi-asserted-by":"crossref","unstructured":"Chandramohan V, Jeay S, Pianetti S, Sonenshein GE. Reciprocal control of Forkhead box O 3a and c-Myc via the phosphatidylinositol 3-kinase pathway coordinately regulates p27Kip1 levels. J Immunol\u20082004;172:5522\u20137.","DOI":"10.4049\/jimmunol.172.9.5522"},{"key":"2022061622284394500_B34","doi-asserted-by":"crossref","unstructured":"Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev\u20082000;14:2501\u201314.","DOI":"10.1101\/gad.836800"},{"key":"2022061622284394500_B35","doi-asserted-by":"crossref","unstructured":"Gregory MA, Hann SR. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol\u20082000;20:2423\u201335.","DOI":"10.1128\/MCB.20.7.2423-2435.2000"},{"key":"2022061622284394500_B36","doi-asserted-by":"crossref","unstructured":"Kamemura K, Hayes BK, Comer FI, Hart GW. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation\/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens. J Biol Chem\u20082002;277:19229\u201335.","DOI":"10.1074\/jbc.M201729200"},{"key":"2022061622284394500_B37","doi-asserted-by":"crossref","unstructured":"Gregory MA, Qi Y, Hann SR. Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J Biol Chem\u20082003;278:51606\u201312.","DOI":"10.1074\/jbc.M310722200"},{"key":"2022061622284394500_B38","doi-asserted-by":"crossref","unstructured":"Rajkumar SV, Richardson PG, Hideshima T, Anderson KC. Proteasome inhibition as a novel therapeutic target in human cancer. J Clin Oncol\u20082005;23:630\u20139.","DOI":"10.1200\/JCO.2005.11.030"},{"key":"2022061622284394500_B39","doi-asserted-by":"crossref","unstructured":"Coghlan MP, Culbert AA, Cross DA, et al. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol\u20082000;7:793\u2013803.","DOI":"10.1016\/S1074-5521(00)00025-9"},{"key":"2022061622284394500_B40","doi-asserted-by":"crossref","unstructured":"Prochownik EV. c-Myc as a therapeutic target in cancer. Expert Rev Anticancer Ther\u20082004;4:289\u2013302.","DOI":"10.1586\/14737140.4.2.289"},{"key":"2022061622284394500_B41","doi-asserted-by":"crossref","unstructured":"Hermeking H. The MYC oncogene as a cancer drug target. Curr Cancer Drug Targets\u20082003;3:163\u201375.","DOI":"10.2174\/1568009033481949"},{"key":"2022061622284394500_B42","doi-asserted-by":"crossref","unstructured":"Berg T, Cohen SB, Desharnais J, et al. Small-molecule antagonists of Myc\/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts. Proc Natl Acad Sci U S A\u20082002;99:3830\u20135.","DOI":"10.1073\/pnas.062036999"},{"key":"2022061622284394500_B43","doi-asserted-by":"crossref","unstructured":"Yin X, Giap C, Lazo JS, Prochownik EV. Low molecular weight inhibitors of Myc-Max interaction and function. Oncogene\u20082003;22:6151\u20139.","DOI":"10.1038\/sj.onc.1206641"},{"key":"2022061622284394500_B44","doi-asserted-by":"crossref","unstructured":"Oster SK, Mao DY, Kennedy J, Penn LZ. Functional analysis of the N-terminal domain of the Myc oncoprotein. Oncogene\u20082003;22:1998\u20132010.","DOI":"10.1038\/sj.onc.1206228"},{"key":"2022061622284394500_B45","doi-asserted-by":"crossref","unstructured":"Yeh E, Cunningham M, Arnold H, et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol\u20082004;6:308\u201318.","DOI":"10.1038\/ncb1110"},{"key":"2022061622284394500_B46","doi-asserted-by":"crossref","unstructured":"Chou TY, Dang CV, Hart GW. Glycosylation of the c-Myc transactivation domain. Proc Natl Acad Sci U S A\u20081995;92:4417\u201321.","DOI":"10.1073\/pnas.92.10.4417"},{"key":"2022061622284394500_B47","doi-asserted-by":"crossref","unstructured":"Ang XL, Wade Harper J. SCF-mediated protein degradation and cell cycle control. Oncogene\u20082005;24:2860\u201370.","DOI":"10.1038\/sj.onc.1208614"},{"key":"2022061622284394500_B48","doi-asserted-by":"crossref","unstructured":"Li YP, Chen Y, Li AS, Reid MB. Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. Am J Physiol Cell Physiol\u20082003;285:C806\u201312.","DOI":"10.1152\/ajpcell.00129.2003"},{"key":"2022061622284394500_B49","doi-asserted-by":"crossref","unstructured":"Jahngen-Hodge J, Obin MS, Gong X, et al. Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress. J Biol Chem\u20081997;272:28218\u201326.","DOI":"10.1074\/jbc.272.45.28218"},{"key":"2022061622284394500_B50","doi-asserted-by":"crossref","unstructured":"Luu HH, Zhang R, Haydon RC, et al. Wnt\/\u03b2-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets\u20082004;4:653\u201371.","DOI":"10.2174\/1568009043332709"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/3\/1775\/2561681\/1775.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/3\/1775\/2561681\/1775.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T21:53:55Z","timestamp":1655416435000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/3\/1775\/527512\/The-Immunomodulatory-Benzodiazepine-Bz-423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,1]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2006,2,1]]},"published-print":{"date-parts":[[2006,2,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-05-3476","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22366634","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22366628","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22366628.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22366634.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6495227.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6495227","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,1]]}}}